Back
Clearside Biomedical Quote, Financials, Valuation and Earnings
Sponsored
CLSD
Sponsored
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
31
CLSD
Clearside Biomedical
Last Price:
1.05
Seasonality Move:
22.36%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereClearside Biomedical Price Quote
$1.05
-0.03 (-2.78%)
(Updated: November 14, 2024 at 5:20 PM ET)
Clearside Biomedical Key Stats
Sell
31
Clearside Biomedical (CLSD)
is a Sell
Day range:
$1.06 - $1.15
52-week range:
$0.90 - $2.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.92
P/B ratio:
0%
Volume:
278.2K
Avg. volume:
1.2M
1-year change:
11.34%
Market cap:
$83M
Revenue:
$8.2M
EPS:
$-0.5
How Much Does Clearside Biomedical Make?
-
How Much Are Clearside Biomedical's Sales Annually?
CLSD Revenues are $8.2M -
How Much Profit Does Clearside Biomedical's Make A Year?
CLSD net income is -$32.5M
Is Clearside Biomedical Growing As A Company?
-
What Is Clearside Biomedical's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.91% -
What Is Clearside Biomedical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Clearside Biomedical Stock Price Performance
-
Did Clearside Biomedical Stock Go Up Last Month?
Clearside Biomedical share price went down by -12.9% last month -
Did CLSD's Share Price Rise Over The Last Year?
CLSD share price rose by 11.34% over the past 1 year
What Is Clearside Biomedical 52-Week High & Low?
-
What Is Clearside Biomedical’s 52-Week High Share Price?
Clearside Biomedical has traded as high as $2.12 over the past 52 weeks -
What Is Clearside Biomedical’s 52-Week Low Share Price?
Clearside Biomedical has traded as low as $0.90 over the past 52 weeks
Clearside Biomedical Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Clearside Biomedical?
-
How Much Debt Does Clearside Biomedical Have?
Total long term debt quarterly is $0 -
How Much Cash Does Clearside Biomedical Have?
Cash and short term investments quarterly total is $29.4M -
What Is Clearside Biomedical’s Book Value Per Share?
Book value per share is -0.38
Is Clearside Biomedical Cash Flow Positive?
-
What Is CLSD Cash Flow From Operations?
Cash flow from operations (TTM) is -$19.1M -
What Is Clearside Biomedical’s Cash Flow From Financing?
Cash flow from financing (TTM) is $14.4M -
What Is Clearside Biomedical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$12.1M
Clearside Biomedical Return On Invested Capital
Data Unavailable
Clearside Biomedical Earnings Date & Stock Price
-
What Is Clearside Biomedical's Stock Price Today?
A single share of CLSD can be purchased today for 1.08 -
What Is Clearside Biomedical’s Stock Symbol?
Clearside Biomedical trades on the nasdaq under the ticker symbol: CLSD -
When Is Clearside Biomedical’s Next Earnings Date?
The next quarterly earnings date for Clearside Biomedical is scheduled on March 12, 2025 -
When Is CLSD's next ex-dividend date?
Clearside Biomedical's next ex-dividend date is November 14, 2024 -
How To Buy Clearside Biomedical Stock?
You can buy Clearside Biomedical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Clearside Biomedical Competitors
-
Who Are Clearside Biomedical's Competitors?
Below is a list of companies who compete with Clearside Biomedical or are related in some way:
Clearside Biomedical Dividend Yield
-
What Is CLSD Dividend Yield?
Clearside Biomedical’s dividend yield currently is 0% -
What Is Clearside Biomedical’s Payout Ratio?
Clearside Biomedical’s payout ratio is 0% -
When Did Clearside Biomedical Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Clearside Biomedical’s Dividend Per Share?
Clearside Biomedical pays a dividend of $0.00 per share
Clearside Biomedical Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 25.93% |
Revenue: | -91.16% | -28.85% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 5.86 |
Upside from Last Price: | 442.33% |